RTTNews - Latest Earnings,Upcoming Earnings, Pos Pre Announcements, Pos Pre Announcements , Positive Surprises, Negative Surprises, Hot Stocks, Stock Split Calendar, Stock Buybacks, Dividends, Negative, Positive PreAnnouncements,Surprises ....

Bristol-Myers Squibb, Otsuka Pharma Reveal FDA Approves ABILIFY For Treatment Of Irritability Associated With Autistic Disorder
11/20/2009 6:51:52 PM RTT News

FDA Says Heartburn Drug Omeprazole Reduces Efficacy Of Blood Thinner Plavix - Update
11/17/2009 11:34:07 PM RTT News

Bristol-Myers Squibb Set New High For Year Monday
11/17/2009 8:49:14 AM RTT News

Bristol-Myers Squibb To Split-off Mead Johnson As Independent BioPharma Company - Update
11/15/2009 9:26:40 PM RTT News

Bristol-Myers Squibb To Split Off Stake In Mead Johnson Nutrition - Quick Facts
11/15/2009 7:23:18 PM RTT News

Bristol-Myers Squibb To Present At Credit Suisse Healthcare Conference; Webcast At 10:30 AM ET
11/12/2009 8:19:51 AM RTT News

Bristol-Myers Squibb To Present At Credit Suisse Healthcare Conference; Webcast At 10:30 AM ET
11/12/2009 6:44:00 AM RTT News

Bristol-Myers Squibb And Alder Announce Deal On ALD518 To Treat Rheumatoid Arthritis - Update
11/10/2009 8:59:44 AM RTT News

Previous 10 Headlines

Press Releases

U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Treatment of Irritability Associated with Autistic Disorder in Pediatric Patients (Ages 6 to 17 Years)
11/20/2009 6:50:03 PM Business Wire

Critical Alerts for Chevron, Bristol-Myers Squibb, Gold Fields, Novellus, and Host Hotels Released by Seven Summits Research
11/20/2009 9:31:07 AM PR Newswire

Bristol-Myers Squibb Announces Split-Off of Mead Johnson
11/15/2009 7:00:03 PM Business Wire

M3 USA and Bristol-Myers Squibb to Launch Next-Generation eMarketing Solution
11/13/2009 8:00:18 AM Business Wire

Bristol-Myers Squibb to Present at Credit Suisse Healthcare Conference
11/10/2009 9:00:41 AM Business Wire

Bristol-Myers Squibb and Alder Biopharmaceuticals Enter Global Agreement on Rheumatoid Arthritis Biologic
11/10/2009 7:00:16 AM Business Wire

BenchmarkJournal.com Free Analyst Review for BMY, ACF, FRE, TD, SWY and CBB
11/6/2009 5:40:01 AM Market Wire

FDA Approves Labeling Update for REYATAZ(R) (atazanavir sulfate) Capsules to Include 96-Week Data for Previously Untreated HIV-1 Infected Adult Patients
11/5/2009 6:09:03 PM Business Wire

BARACLUDE(R) (entecavir) Demonstrated Greater Antiviral Efficacy Compared to Adefovir in New Study of Chronic Hepatitis B Patients with Evidence of Decompensated Cirrhosis
10/31/2009 5:31:02 PM Business Wire

Bristol-Myers Squibb and ZymoGenetics Present Final Phase 1b Results for PEG-Interferon Lambda in Hepatitis C
10/31/2009 5:30:49 PM Business Wire

Previous10 Headlines